American International Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-489
| Closed | -$72 | – | 3310 |
|
|
2021
Q1 | $72 | Buy |
489
+1
| +0.2% | – | ﹤0.01% | 2866 |
|
|
2020
Q4 | $68 | Sell |
488
-14
| -3% | -$2 | ﹤0.01% | 2851 |
|
|
2020
Q3 | $76K | Sell |
502
-26
| -5% | -$3.94K | ﹤0.01% | 2674 |
|
|
2020
Q2 | $93K | Buy |
+528
| New | +$93K | ﹤0.01% | 2579 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$2K | – | 5092 |
|
|
2015
Q3 | $2K | Sell |
1
-1
| -50% | -$2K | ﹤0.01% | 4833 |
|
|
2015
Q2 | $1.83K | Sell |
2
-31
| -94% | -$28.3K | ﹤0.01% | 4917 |
|
|
2015
Q1 | $33.6K | Hold |
33
| – | – | ﹤0.01% | 4133 |
|
|
2014
Q4 | $110K | Sell |
33
-1
| -3% | -$3.34K | ﹤0.01% | 3504 |
|
|
2014
Q3 | $99.7K | Hold |
34
| – | – | ﹤0.01% | 3556 |
|
|
2014
Q2 | $131K | Buy |
+34
| New | +$131K | ﹤0.01% | 3369 |
|